1
|
Ross R: Cell biology of atherosclerosis.
Annu Rev Physiol. 57:791–804. 1995. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jawien A, Bowen-Pope DF, Lindner V,
Schwartz SM and Clowes AW: Platelet-derived growth factor promotes
smooth muscle migration and intimal thickening in a rat model of
balloon angioplasty. J Clin Invest. 89:507–511. 1992. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ferns GA, Raines EW, Sprugel KH, Motani
AS, Reidy MA and Ross R: Inhibition of neointimal smooth muscle
accumulation after angioplasty by an antibody to PDGF. Science.
253:1129–1132. 1991. View Article : Google Scholar : PubMed/NCBI
|
4
|
Owens GK, Kumar MS and Wamhoff BR:
Molecular regulation of vascular smooth muscle cell differentiation
in development and disease. Physiol Rev. 84:767–801. 2004.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao
T, Miyazaki H and Iwao H: Role of JNK, p38, and ERK in
platelet-derived growth factor-induced vascular proliferation,
migration, and gene expression. Arterioscler Thromb Vasc Biol.
23:795–801. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Sherr CJ: G1 phase progression: cycling on
cue. Cell. 79:551–555. 1994. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
8
|
Gordon D, Reidy MA, Benditt EP and
Schwartz SM: Cell proliferation in human coronary arteries. Proc
Natl Acad Sci USA. 87:4600–4604. 1990. View Article : Google Scholar : PubMed/NCBI
|
9
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Toyoshima H and Hunter T: p27, a novel
inhibitor of G1 cyclin-Cdk protein kinase activity, is related to
p21. Cell. 78:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
11
|
Weiss RH, Joo A and Randour C:
p21(Waf1/Cip1) is an assembly factor required for platelet-derived
growth factor-induced vascular smooth muscle cell proliferation. J
Biol Chem. 275:10285–10290. 2000. View Article : Google Scholar : PubMed/NCBI
|
12
|
Moon SK, Kim HM, Lee YC and Kim CH:
Disialoganglioside (GD3) synthase gene expression suppresses
vascular smooth muscle cell responses via the inhibition of ERK1/2
phosphorylation, cell cycle progression, and matrix
metalloproteinase-9 expression. J Biol Chem. 279:33063–33070. 2004.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Senior RM, Griffin GL, Fliszar CJ, Shapiro
SD, Goldberg GI and Welgus HG: Human 92- and 72-kilodalton type IV
collagenases are elastases. J Biol Chem. 266:7870–7875.
1991.PubMed/NCBI
|
14
|
Newby AC and Zaltsman AB: Molecular
mechanisms in intimal hyperplasia. J Pathol. 190:300–309. 2000.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Cho A and Reidy MA: Matrix
metalloproteinase-9 is necessary for the regulation of smooth
muscle cell replication and migration after arterial injury. Circ
Res. 91:845–851. 2002. View Article : Google Scholar : PubMed/NCBI
|
16
|
Galis ZS, Johnson C, Godin D, Magid R,
Shipley JM, Senior RM and Ivan E: Targeted disruption of the matrix
metalloproteinase-9 gene impairs smooth muscle cell migration and
geometrical arterial remodeling. Circ Res. 91:852–859. 2002.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Cho A, Graves J and Reidy MA:
Mitogen-activated protein kinases mediate matrix
metalloproteinase-9 expression in vascular smooth muscle cells.
Arterioscler Thromb Vasc Biol. 20:2527–2532. 2000. View Article : Google Scholar : PubMed/NCBI
|
18
|
Moon SK, Cha BY and Kim CH: ERK1/2
mediates TNF-alpha-induced matrix metalloproteinase-9 expression in
human vascular smooth muscle cells via the regulation of NF-kappaB
and AP-1: involvement of the ras dependent pathway. J Cell Physiol.
198:417–427. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Bond M, Chase AJ, Baker AH and Newby AC:
Inhibition of transcription factor NF-kappaB reduces matrix
metalloproteinase-1, -3 and -9 production by vascular smooth muscle
cells. Cardiovasc Res. 50:556–565. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
Choi EM and Hwang JK: Investigations of
anti-inflammatory and antinociceptive activities of Piper cubeba,
Physalis angulata and Rosa hybrida. J Ethnopharmacol. 89:171–175.
2003. View Article : Google Scholar : PubMed/NCBI
|
21
|
Yang G, Park D, Lee SH, Bae DK, Yang YH,
Kyung J, Kim D, Choi EK, Hong JT, Jeong HS, et al: Neuroprotective
effects of a butanol fraction of Rosa hybrida petals in a middle
cerebral artery occlusion model. Biomol Ther (Seoul). 21:454–461.
2013. View Article : Google Scholar
|
22
|
Lee HR and Lee JM, Choi NS and Lee JM: The
antioxidative and antimicrobial ability of ethanol extracts from
Rosa hybrida. Korean J Food Sci Technol. 35:373–378. 2003.
|
23
|
Lee SJ, Park SS, Kim WJ and Moon SK:
Gleditsia sinensis thorn extract inhibits proliferation and
TNF-α-induced MMP-9 expression in vascular smooth muscle cells. Am
J Chin Med. 40:373–386. 2012. View Article : Google Scholar
|
24
|
Lee HJ, Kim HS, Kim ST, Park D, Hong JT,
Kim YB and Joo SS: Anti-inflammatory effects of hexane fraction
from white rose flower extracts via inhibition of inflammatory
repertoires. Biomol Ther (Seoul). 19:331–335. 2011. View Article : Google Scholar
|